Hydroxychloroquine as an Adjunct Therapy for Diabetes in Pregnancy

3Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

This review discusses the pathophysiology of diabetes in pregnancy in relation to the placental function. We review the potential use of hydroxychloroquine in improving pregnancy outcomes affected by diabetes. The review focuses on the mechanism of action of hydroxychloroquine and its potential effects on diabetes. There are several pathways in which hydroxychloroquine mediates its effects: through the inflammasome complex, inflammatory cytokines, oxidative stress, modulatory effects, and antihyperglycemic effects. As a safe drug to be used in pregnancy, it is worth exploring the possible use hydroxychloroquine as an adjunct treatment to the current therapy of diabetes in pregnancy.

Cite

CITATION STYLE

APA

Basri, N. I., Murthi, P., & Abd Rahman, R. (2024, September 1). Hydroxychloroquine as an Adjunct Therapy for Diabetes in Pregnancy. International Journal of Molecular Sciences. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/ijms25179681

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free